MARK4 Antikörper (Internal Region)
Kurzübersicht für MARK4 Antikörper (Internal Region) (ABIN784580)
Target
Alle MARK4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Internal Region
-
Spezifität
- This antibody detects endogenous levels of total MARK4 protein.
-
Kreuzreaktivität (Details)
-
Species reactivity (expected):Mouse.
Species reactivity (tested):Human. -
Aufreinigung
- Immunoaffinity Chromatography
-
Immunogen
- Synthetic peptide Remarks: Antigen Modification: Internal
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS (without Mg2+, Ca2+), pH 7.4, 150 mM Sodium Chloride, 0.02 % Sodium Azide and 50 % Glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store the antibody (in aliquots) at -20 °C. Avoid freeze-thaw cycles.
-
-
- MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))
-
Andere Bezeichnung
- MARK4
-
Hintergrund
- MARKL1, a MARK type protein kinase, contains a N-terminal serine/threonine kinase domain, a central ubiquitin-associated domain and a C-terminal KA1-associated kinase domain. A smaller mRNA transcript, lacking exon 16 containing the KA1-associated kinase domain, also has been reported.Synonyms: MAP microtubule affinity-regulating kinase 4, MARKL1
-
Gen-ID
- 57787
-
NCBI Accession
- NP_001186796
Target
-